Tumour lysis syndrome in patients with chronic lymphocytic leukaemia treated with BCL-2 inhibitors: risk factors, prophylaxis, and treatment recommendations

Francesco Paolo Tambaro, William G. Wierda

Research output: Contribution to journal › Review article › peer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Tumour lysis syndrome in patients with chronic lymphocytic leukaemia treated with BCL-2 inhibitors: risk factors, prophylaxis, and treatment recommendations'. Together they form a unique fingerprint.

Medicine & Life Sciences